Get research updatesSchizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
The Effects of Resourcefulness Group Intervention on Recovery and Quality of Life in Patients With Chronic Schizophrenia.
This study has finished and is no longer accepting participants.
In New Taipei City
Role of an E-cigarette on Smoking Displacement in Smokers With Schizophrenia: A Prospective 3-month Pilot Study
This study has finished and is no longer accepting participants.
In New YorkRole of Selected Antioxidants (Vitamin C and E) in the Management of Schizophrenia
This study has finished and is no longer accepting participants.
In Lahore
Safety and Efficacy of Zicronapine in Patients With Schizophrenia
Read the official source — NCT01295372Researchers compared Zicronapine and Risperidone to find out how the approaches affected body weight in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including BrnoSix Week, Double-Blind, Placebo Controlled Phase III Trial Evaluating The Efficacy, Safety And Pharmacokinetics Of Flexible Doses Of Oral Ziprasidone In Adolescent Subjects With Schizophrenia
This study ended early.
Multiple locations, including BirminghamA Phase 1, Randomized, Placebo- Controlled, Double-Blind Safety, Tolerability, Pharmacokinetic, and Exploratory Pharmacodynamic Study in Healthy Subjects and Subjects With Stable Schizophrenia After Multiple Doses of ITI-214
This study ended early.
Multiple locations, including GlendaleResearchers studied Risperidone implant, tracking side effects to assess safety and tolerability in people with schizophrenia.
This study has finished and is no longer accepting participants.
In Garden Grove26-Week Open-Label Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Adolescent Subjects With Schizophrenia
This study ended early.
Multiple locations, including BirminghamResearchers compared Lu AF11167 and placebo, tracking side effects to assess safety and tolerability in people with schizophrenia.
This study has finished and is no longer accepting participants.
In GlendaleThis study evaluated the safety of Lu AF35700 for people with schizophrenia.
This study has finished and is no longer accepting participants.
In GlendaleA Phase 1, Two-part, Open-label, Randomized, Exploratory and Single Ascending Dose, Parallel Arm Trial to Determine the Pharmacokinetics, Safety, and Tolerability of Brexpiprazole Long-acting Injectable Administered Subcutaneously or Intramuscularly in Adult Subjects With Schizophrenia
This study ended early.
Multiple locations, including Garden GroveSafety and Tolerability Trial of Aripiprazole IM Depot Treatment in Adult Subjects With Schizophrenia Stabilized on Oral Antipsychotics Other Than Aripiprazole
Read the official source — NCT01552772Researchers studied Aripiprazole IM Depot, tracking side effects to assess safety and tolerability in adults with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including AnaheimWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.